Study of Nutritional Factors in Porphyria
NCT00004788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2005-06-24
Summary
OBJECTIVES: I. Determine whether differences in dietary habits are associated with disease activity in patients with acute intermittent porphyria.
II. Determine whether premenstrual porphyria attacks are associated with increased luteal phase energy requirements.
III. Determine whether energy requirements are higher than intakes in men with unexplained frequent porphyria attacks.
IV. Assess the nutritional status of women with acute intermittent porphyria using a comprehensive series of laboratory methods, including zinc and pyridoxine status.
V. Determine whether the frequency of disease exacerbations decreases when dietary and nutritional abnormalities are corrected in these patients.
VI. Evaluate the safety and efficacy of a parenteral nutrition regimen for patients with acute porphyria attacks.
Conditions
- Porphyria
Sponsors & Collaborators
-
University of Texas
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Karl Elmo Anderson · University of Texas
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1988-05-31
More Related Trials
-
Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)
NCT01617642 ·Status: ACTIVE_NOT_RECRUITING
-
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
NCT03906214 ·Status: COMPLETED
-
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
NCT01688895 ·Status: COMPLETED
-
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
NCT04754711 ·Status: COMPLETED ·Phase: NA
-
Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
NCT00004789 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System
NCT05882136 ·Status: COMPLETED
-
Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
NCT00004398 ·Status: COMPLETED ·Phase: PHASE1
-
Panhematin for Prevention of Acute Attacks of Porphyria
NCT02922413 ·Status: TERMINATED ·Phase: PHASE2
-
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 ·Status: RECRUITING
-
Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
NCT00004397 ·Status: COMPLETED ·Phase: PHASE1
-
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891 ·Status: COMPLETED
-
Oral Iron for Erythropoietic Protoporphyrias
NCT02979249 ·Status: COMPLETED ·Phase: NA
-
Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria
NCT02180412 ·Status: COMPLETED ·Phase: PHASE2
-
Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))
NCT01880983 ·Status: COMPLETED
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
NCT00011648 ·Status: COMPLETED
-
Full Assessment of Clinical Transfusion Support
NCT07094646 ·Status: COMPLETED
-
Iron Deficiency in Female State Fair Attendees
NCT03228173 ·Status: COMPLETED
-
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
NCT07083531 ·Status: RECRUITING
-
Frequency and Impact of Iron Deficiency in Pain Clinic Patients
NCT06665516 ·Status: COMPLETED
-
Iron Therapy in Erythropoietic Protoporphyria
NCT05572125 ·Status: COMPLETED
-
Sickle Cell Clinical Research and Intervention Program
NCT02098863 ·Status: RECRUITING
-
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
NCT03685721 ·Status: RECRUITING
-
Kidney Function in Sickle Cell Anemia
NCT03277547 ·Status: ACTIVE_NOT_RECRUITING
-
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
NCT01054768 ·Status: COMPLETED ·Phase: PHASE2